Jun Kawashima
Impact in
- Genetics top 1%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Hemoglobinopathies and Related Disorders
- Hematology top 2%
- Chronic Myeloid Leukemia Treatments
- Acute Myeloid Leukemia Research
Papers in
- Hepatology 27
- Hepatocellular Carcinoma Treatment and Prognosis 27
- Genetics 23
- Myeloproliferative Neoplasms: Diagnosis and Treatment 23
- Co-authors
- Vikas Gupta (18 shared papers)Srđan Verstovšek (14 shared papers)Jean‐Jacques Kiladjian (12 shared papers)Uwe Platzbecker (9 shared papers)David Lavie (8 shared papers)Alessandro Maria Vannucchi (9 shared papers)Claire Harrison (6 shared papers)Ruben A. Mesa (14 shared papers)
- Journals
- Annals of Surgical Oncology (18 papers)Blood (9 papers)HPB (8 papers)Journal of Gastrointestinal Surgery (7 papers)European Journal of Surgical Oncology (7 papers)
- Partner nations
- United StatesJapanItaly
In The Last Decade
Jun Kawashima
83 papers receiving 1.1k citations
Jun Kawashima's Hit Papers
Peers
Comparison fields: 5 of 55
- Genetics 789
- Hematology 486
- Rheumatology 198
- Hepatology 56
- Molecular Biology 429
Countries citing papers authored by Jun Kawashima
This map shows the geographic impact of Jun Kawashima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jun Kawashima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jun Kawashima more than expected).
Fields of papers citing papers by Jun Kawashima
This network shows the impact of papers produced by Jun Kawashima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jun Kawashima. The network helps show where Jun Kawashima may publish in the future.
Co-authors
The 25 scholars most cited alongside Jun Kawashima, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 101 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 259 | |
| 2 | Momelotinib versus danazol in symptomatic patients with anaemia and myelofibrosis (MOMENTUM): results from an international, double-blind, randomised, controlled, phase 3 study Hit paper breakdown → | 2023 | 141 |
| 3 | 2020 | 109 | |
| 4 | 2016 | 89 | |
| 5 | 2017 | 58 | |
| 6 | 2023 | 39 | |
| 7 | 2013 | 38 | |
| 8 | 2023 | 31 | |
| 9 | 1994 | 23 | |
| 10 | 1994 | 21 | |
| 11 | 2018 | 21 | |
| 12 | 2012 | 16 | |
| 13 | 2024 | 16 | |
| 14 | 2024 | 16 | |
| 15 | 2021 | 14 | |
| 16 | 2017 | 14 | |
| 17 | 2023 | 13 | |
| 18 | 2023 | 12 | |
| 19 | 2024 | 9 | |
| 20 | 2024 | 9 |
About Jun Kawashima
Jun Kawashima is a scholar working on Hepatology, Genetics, Hematology, Surgery and Oncology, having authored 101 papers that have together received 1.1k indexed citations. Recurring topics across this work include Hepatocellular Carcinoma Treatment and Prognosis (27 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (23 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (20 papers), Chronic Myeloid Leukemia Treatments (15 papers), Kruppel-like factors research (8 papers), Pancreatic and Hepatic Oncology Research (5 papers), Liver Disease Diagnosis and Treatment (4 papers) and Eosinophilic Disorders and Syndromes (4 papers). The work is most often cited by research in Genetics (789 citations), Hematology (486 citations), Rheumatology (198 citations), Hepatology (56 citations) and Molecular Biology (429 citations). Jun Kawashima has collaborated with scholars based in United States, Japan and Italy. Frequent co-authors include Vikas Gupta, Srđan Verstovšek, Jean‐Jacques Kiladjian, Uwe Platzbecker, David Lavie, Alessandro Maria Vannucchi, Claire Harrison, Ruben A. Mesa, Francisco Cervantes and Elliott F. Winton. Their work appears in journals such as Annals of Surgical Oncology, Blood, HPB, Journal of Gastrointestinal Surgery and European Journal of Surgical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.